Haemonetics | HAE - Zinsaufwendungen Für Schuld

Aktienkurs
59.19
Täglich Wechseln
-0.37 -0.62%
Monatlich
-7.85%
Jährlich
-3.01%
Q2 Prognose
55.12




Zinsaufwendungen Für Schuld Veränderung Datum
Avanos Medical USD 1.9M 100K 2025-12
Baxter International USD 58M 14M 2025-09
Becton, Dickinson and Co. USD 153M 2M 2025-12
Boston Scientific USD 90M 3M 2025-12
Cerus USD 2.33M 96K 2024-06
Cooper Companies USD 22.4M 2M 2025-12
Fresenius EUR 81M 5M 2025-09
Fresenius Medical Care EUR 85M 8.1M 2025-12
Globus Medical USD 17K 5.1B 2025-12
Haemonetics USD 7.21M 3.14M 2025-09
Hologic USD 27.6M 1000K 2025-12
ICU Medical USD 20.64M 21.39M 2025-12
Intuitive Surgical USD 19.35B 811.4M 2025-09
Masimo USD 7.5M 1.3M 2025-12
Medtronic USD 181M 0 2025-12
Merit Medical Systems USD 6.36M 390K 2025-12
Neogen USD 14.26M 1.26M 2025-09
OraSure Technologies 1.67M 1.13M 2025-12
Plus Therapeutics USD 62K 25K 2023-12
Quidel USD 5.68B 5.63B 2025-09
ResMed USD 8.79M 14.55M 2025-09
STAAR Surgical USD 800K 799K 2025-09
Steris USD 14.9M 0 2025-12
Stryker USD 157M 46.17B 2025-09
Surmodics USD 884K 5K 2024-09
Teleflex USD 28.15M 3.69M 2025-12
Terumo JPY 463M 445M 2025-12
Thermo Fisher Scientific USD 365M 18M 2025-12
US Physical Therapy USD 2.35M 58K 2025-12
Zimmer Biomet Holdings USD 71.9M 3.5M 2025-12